Pulmonx (LUNG) Other Non-Current Liabilities (2019 - 2022)
Pulmonx (LUNG) posted quarterly Other Non-Current Liabilities of $179000.0 for Q2 2022, little changed quarter-over-quarter from $179000.0 in Q1 2022.
Pulmonx (LUNG) Other Non-Current Liabilities (2019 - 2022) Analysis & Trends
Pulmonx (LUNG) has reported Other Non-Current Liabilities for 4 consecutive years, with $179000.0 the latest figure, recorded in Q2 2022.
- In Q2 2022, Other Non-Current Liabilities changed N/A year-over-year to $179000.0; the TTM figure through Jun 2022 stood at $179000.0 (changed N/A YoY), while the FY2021 annual figure was $179000.0, changed N/A from the prior year.
- Other Non-Current Liabilities was little changed at $179000.0 in Q2 2022 per LUNG's latest filing, from $179000.0 in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $1.9 million in Q3 2020 and bottomed at $179000.0 in Q4 2021.
- Historically, Other Non-Current Liabilities has averaged $727400.0 across 4 years, with a median of $179000.0 in 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn |
| 10 | Pulmonx | 94.15 Mn | 24.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 179,000.00 |
| Mar 31, 2022 | 179,000.00 |
| Dec 31, 2021 | 179,000.00 |
| Sep 30, 2020 | 1.90 Mn |
| Dec 31, 2019 | 1.20 Mn |